FR2776516B1 - COMPOSITIONS HAVING SUSTAINED RELEASE AND THEIR PREPARATION METHOD - Google Patents

COMPOSITIONS HAVING SUSTAINED RELEASE AND THEIR PREPARATION METHOD

Info

Publication number
FR2776516B1
FR2776516B1 FR9803666A FR9803666A FR2776516B1 FR 2776516 B1 FR2776516 B1 FR 2776516B1 FR 9803666 A FR9803666 A FR 9803666A FR 9803666 A FR9803666 A FR 9803666A FR 2776516 B1 FR2776516 B1 FR 2776516B1
Authority
FR
France
Prior art keywords
compositions
preparation
sustained release
sustained
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9803666A
Other languages
French (fr)
Other versions
FR2776516A1 (en
Inventor
Marc Pellet
Chantal Roume
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharma Biotech
Original Assignee
Pharma Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Biotech filed Critical Pharma Biotech
Priority to FR9803666A priority Critical patent/FR2776516B1/en
Priority to MYPI98001698A priority patent/MY118835A/en
Priority to TW087105802A priority patent/TW577759B/en
Priority to ARP980101756A priority patent/AR012448A1/en
Priority to HU0004297A priority patent/HUP0004297A2/en
Priority to CNB031545998A priority patent/CN1313082C/en
Priority to DK98921551T priority patent/DK0980240T3/en
Priority to AT98921551T priority patent/ATE389388T1/en
Priority to PL336296A priority patent/PL196771B1/en
Priority to AU74363/98A priority patent/AU741964B2/en
Priority to DE69839264T priority patent/DE69839264T2/en
Priority to CZ0362699A priority patent/CZ297078B6/en
Priority to EP98921551A priority patent/EP0980240B1/en
Priority to RU99124209/14A priority patent/RU2198678C2/en
Priority to IL13221798A priority patent/IL132217A/en
Priority to ES98921551T priority patent/ES2303353T3/en
Priority to US09/403,058 priority patent/US6217893B1/en
Priority to JP54515098A priority patent/JP4557312B2/en
Priority to PCT/FR1998/000773 priority patent/WO1998047489A1/en
Priority to CNB988052202A priority patent/CN1144584C/en
Priority to BR9808933-1A priority patent/BR9808933A/en
Priority to CA2286575A priority patent/CA2286575C/en
Priority to PT98921551T priority patent/PT980240E/en
Publication of FR2776516A1 publication Critical patent/FR2776516A1/en
Priority to NO19995063A priority patent/NO327999B1/en
Priority to US09/707,372 priority patent/US6475507B1/en
Priority to HK00107498A priority patent/HK1027983A1/en
Application granted granted Critical
Publication of FR2776516B1 publication Critical patent/FR2776516B1/en
Priority to ARP070102999A priority patent/AR061828A2/en
Priority to NO20080803A priority patent/NO20080803L/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
FR9803666A 1997-04-18 1998-03-25 COMPOSITIONS HAVING SUSTAINED RELEASE AND THEIR PREPARATION METHOD Expired - Lifetime FR2776516B1 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
FR9803666A FR2776516B1 (en) 1998-03-25 1998-03-25 COMPOSITIONS HAVING SUSTAINED RELEASE AND THEIR PREPARATION METHOD
TW087105802A TW577759B (en) 1997-04-18 1998-04-16 Sustained release compositions in the form of microcapsules or implants and the process for their preparation
ARP980101756A AR012448A1 (en) 1997-04-18 1998-04-16 COMPOSITION IN THE FORM OF MICROCAPSULES OR IMPLANTS COMPRISING A BIODEGRADABLE CONTAINER, POLYMER OR CO-POLYMER, OR A MIXTURE OF SUCH EXCIPIENTS, AND AN ACTIVE SUBSTANCE OR MIXTURE OF ACTIVE SUBSTANCES, PROCEDURE FOR THE PREPARATION OF A SUBSTANCE IN A SUBSTANCE
MYPI98001698A MY118835A (en) 1997-04-18 1998-04-16 Sustained release compositions and the process for their preparation
CNB988052202A CN1144584C (en) 1997-04-18 1998-04-17 Sustained-release compositions and method for preparing same
DK98921551T DK0980240T3 (en) 1997-04-18 1998-04-17 Long release compositions and processes for their preparation
AT98921551T ATE389388T1 (en) 1997-04-18 1998-04-17 SUSTAINED RELEASE COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
PL336296A PL196771B1 (en) 1997-04-18 1998-04-17 Composition of retarded active substance release and method of obtaining them
AU74363/98A AU741964B2 (en) 1997-04-18 1998-04-17 Sustained-release compositions and method for preparing same
DE69839264T DE69839264T2 (en) 1997-04-18 1998-04-17 COMPOSITIONS WITH DELAYED RELEASE AND METHOD FOR THE PRODUCTION THEREOF
CZ0362699A CZ297078B6 (en) 1997-04-18 1998-04-17 Composition in the form of microcapsules or implants
EP98921551A EP0980240B1 (en) 1997-04-18 1998-04-17 Sustained-release compositions and method for preparing same
RU99124209/14A RU2198678C2 (en) 1997-04-18 1998-04-17 Sustained-release compositions and method of their preparing
IL13221798A IL132217A (en) 1997-04-18 1998-04-17 Substained-release compositions and method for preparing same
HU0004297A HUP0004297A2 (en) 1997-04-18 1998-04-17 Sustained-release compositions and method for preparing same
US09/403,058 US6217893B1 (en) 1997-04-18 1998-04-17 Sustained-release compositions and method for preparing same
JP54515098A JP4557312B2 (en) 1997-04-18 1998-04-17 Sustained release composition and method for producing the same
PCT/FR1998/000773 WO1998047489A1 (en) 1997-04-18 1998-04-17 Sustained-release compositions and method for preparing same
CNB031545998A CN1313082C (en) 1997-04-18 1998-04-17 Slow releasing composition and its preparing method
BR9808933-1A BR9808933A (en) 1997-04-18 1998-04-17 Composition in the form of microcapsules or implants, process for the preparation of a water-soluble substance, active substance, triptorelin acetate, lanreotide acetate, or octreotide acetate, and double-stranded rna
CA2286575A CA2286575C (en) 1997-04-18 1998-04-17 Sustained-release compositions and method for preparing same
PT98921551T PT980240E (en) 1997-04-18 1998-04-17 Sustained-release compositions and method for preparing same
ES98921551T ES2303353T3 (en) 1997-04-18 1998-04-17 COMPOSITIONS THAT PRESENT A PROLONGED RELEASE AND ITS PREPARATION PROCEDURE.
NO19995063A NO327999B1 (en) 1997-04-18 1999-10-15 Delayed release preparations
US09/707,372 US6475507B1 (en) 1997-04-18 2000-11-06 Sustained release compositions and the process for their preparation
HK00107498A HK1027983A1 (en) 1997-04-18 2000-11-23 Sustained-release compositions and method for preparing same.
ARP070102999A AR061828A2 (en) 1997-04-18 2007-07-05 PROCEDURE FOR THE PREPARATION OF A SOLUBLE SUBSTANCE IN ELEVATED WATER SPECIFIC SURFACE AREA
NO20080803A NO20080803L (en) 1997-04-18 2008-02-14 Delayed release preparations and the process for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9803666A FR2776516B1 (en) 1998-03-25 1998-03-25 COMPOSITIONS HAVING SUSTAINED RELEASE AND THEIR PREPARATION METHOD

Publications (2)

Publication Number Publication Date
FR2776516A1 FR2776516A1 (en) 1999-10-01
FR2776516B1 true FR2776516B1 (en) 2001-05-25

Family

ID=9524471

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9803666A Expired - Lifetime FR2776516B1 (en) 1997-04-18 1998-03-25 COMPOSITIONS HAVING SUSTAINED RELEASE AND THEIR PREPARATION METHOD

Country Status (1)

Country Link
FR (1) FR2776516B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160106804A1 (en) * 2014-10-15 2016-04-21 Yuhua Li Pharmaceutical composition with improved stability

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH661206A5 (en) * 1983-09-23 1987-07-15 Debiopharm Sa PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HORMONDEPENDENT DISEASES.
US5021554A (en) * 1989-02-24 1991-06-04 Eli Lilly And Company Process for protein particle size reduction using a fluid-energy mill
GB2246514B (en) * 1990-08-01 1993-12-15 Scras Sustained release pharmaceutical compositions and the preparation of particles for use therein
DE4041563A1 (en) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh METHOD FOR PRODUCING ACTIVE MICROPARTICLES FROM HYDROLYTICALLY DEGRADABLE POLYMERS
DE4223169C1 (en) * 1992-07-10 1993-11-25 Ferring Arzneimittel Gmbh Process for the microencapsulation of water-soluble active substances
FR2693905B1 (en) * 1992-07-27 1994-09-02 Rhone Merieux Process for the preparation of microspheres for the sustained release of the hormone LHRH and its analogs, microspheres and formulations obtained.
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent

Also Published As

Publication number Publication date
FR2776516A1 (en) 1999-10-01

Similar Documents

Publication Publication Date Title
NO20012857D0 (en) Controlled release galantamine composition
PT945132E (en) COMPOSITION OF IBUPPHENE
DK0922386T3 (en) Controlled release compositions
IL132145A0 (en) Methods and compositions for treating inflammatory bowel disease
DE69924381D1 (en) EASILY FALLING SOLID PREPARATION
PT1066027E (en) PHARMACEUTICAL COMPOSITION OF TOPIRAMATO
ID26549A (en) EPOTILON COMPOSITIONS
ATE367793T1 (en) SWEAT-INHIBITING COMPOSITIONS
NO20005215L (en) dihydropyrimidine
DK1032542T3 (en) Mineral Composition
NO20012467L (en) Dispersible phospholipid stabilized microparticles
PL331983A1 (en) Solid deodorising composition
ATE469550T1 (en) ANTIPARASIC COMPOSITIONS
DK0954966T3 (en) Polymeric controlled release compositions
DE69900144T2 (en) Cellulose ester composition
DE69935172D1 (en) Imidosilane compositions
ID27889A (en) POLYCLIC COOPOLYMER COMPOSITIONS
GB9809213D0 (en) Pharmaceutical compositions
EG24463A (en) Modified release pharmaceutical composition
ID22840A (en) PROCESS FOR PREPARATION OF ASPHALT COMPOSITION
DE69926822D1 (en) Bolt synchronizer
FR2776516B1 (en) COMPOSITIONS HAVING SUSTAINED RELEASE AND THEIR PREPARATION METHOD
HUP0101326A3 (en) Paroxetine compositions and process for their preparation
DE59913470D1 (en) teasel
IT1302028B1 (en) EXPANDING COMPOSITIONS

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20